Mario Gabelli acquired 100k Neogenomics shares worth $1.15M. That's 0.01% of their equity portfolio (598th largest holding). The first Neogenomics trade was made in Q2 2014. Since then Mario Gabelli bought shares thirteen more times and sold shares on 21 occasions. The stake costed the investor $1.05M, netting the investor a gain of 8.9% so far.